Triple-negative breast cancer is one of the most lethal human cancers characterized by the high aggressiveness and heterogeneity and absence of the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.